StageZero Life Sciences Ltd. News Releases

StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

Tue, 20 Jun 2023 07:29:00 -0400

Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announces that it has applied to the Toronto Stock Exchange (the "Exchange") for a temporary repricing of the exercise price of 8,730,647 outstanding...

StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting

Wed, 07 Jun 2023 19:28:00 -0400

Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all of the tabled resolutions listed in the Company's management information circular dated April 28 2023 (the "Circular"), at its annual and special meeting of shareholders held on June 07, 2023(the "Meeting").The results of the vote for the election of directors are as follows:ForWithheldJames...

StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Mon, 05 Jun 2023 17:17:00 -0400

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special and Annual General Meeting of Shareholders on Wednesday June 7, 2023, so that all shareholders may follow along with the proceedings of the meeting.Annual General and Special Meeting Conference CallEvent Date: Wednesday June 7, 2023Time: 2:00pm ETWebcast Link:...

StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update

Tue, 16 May 2023 07:00:00 -0400

Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced its first quarter financial results for the three months ended March 31, 2023, and provided an update on its business operations.For the quarter ended...

StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023

Mon, 15 May 2023 10:51:00 -0400

Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results after the market closes on Monday May 15, 2023. StageZero's Chairman and CEO, James Howard-Tripp, will host an investor webcast and conference call at 8:30am ET on Tuesday May 16, 2023, reviewing the operational results and discussing business developments.Analyst and Investor CallEvent Date: Tuesday...

StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update

Fri, 31 Mar 2023 21:22:00 -0400

Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced its fourth quarter and full year financial results for the three and twelve-months ended December 31, 2022, and provided an update on its business...

StageZero to Issue Q4 2022 Financial Results on Friday March 31

Thu, 30 Mar 2023 15:06:00 -0400

Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational results after the market closes on Friday March 31, 2023. StageZero's Chairman and CEO, James Howard-Tripp, will release a webcast presentation at 7:00am ET on Monday April 3, 2023, reviewing the operational results and discussing business developments.Analyst and Investor CallEvent Date:...

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

Wed, 29 Mar 2023 19:10:00 -0400

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational results after the market closes on Thursday March 30, 2023. StageZero's Chairman and CEO, James Howard-Tripp, will host a conference call and accompanying webcast at 6:00 p.m. ET on Thursday March 30, 2023, to review the operational results and discuss business developments.Analyst and...